MyAverix Finance
SHG · Healthcare
Gempharmatech Co. Ltd. A (688046)
Biotechnology
Gempharmatech Co. Ltd. A (688046) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $6.00B, P/E ratio is 48.77, net margin is 18.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688046
Gempharmatech Co. Ltd. A (688046) — FAQ
What is Gempharmatech Co. Ltd. A's market cap?
Gempharmatech Co. Ltd. A (688046) has a reported market cap of $6.00B (data as of 2026-03-29).
What is 688046's P/E ratio?
The price-to-earnings (P/E) ratio for Gempharmatech Co. Ltd. A (688046) is 48.77 (data as of 2026-03-29).
Does Gempharmatech Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Gempharmatech Co. Ltd. A (688046). Check the MyAverix Finance app for the latest dividend data.
What sector is Gempharmatech Co. Ltd. A in?
Gempharmatech Co. Ltd. A (688046) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688046 listed on?
688046 is listed on SHG.
What is Gempharmatech Co. Ltd. A's net margin?
Gempharmatech Co. Ltd. A (688046) reports a net margin of 18.2% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.